India Glycols Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on March 24, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
INDIAGLYCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
India Glycols Limited held a court-convened meeting of equity shareholders on March 24, 2026 via video conferencing, as ordered by the NCLT Allahabad Bench, to seek approval for a Scheme of Arrangement involving the company (as Demerged Company), Ennature Bio Pharma Limited (Resulting Company 1), and IGL Spirits Limited (Resulting Company 2) under Sections 230-232 of the Companies Act, 2013. A total of 49 shareholders attended the meeting, with 4,42,48,626 votes (66.02% of total shares) being polled. The resolution was passed with virtually unanimous support, with 4,42,48,625 votes (100%) in favour and just 1 vote against. Promoters (3,99,67,854 shares), public institutions (39,81,677 shares), and public non-institutions all voted overwhelmingly in favour of the scheme.
The scheme of arrangement has cleared a major hurdle with overwhelming shareholder approval. The next steps would involve final NCLT sanctioning and regulatory approvals before the demerger/restructuring can take effect, which could unlock value for shareholders through the creation of separate listed entities (Ennature Bio Pharma and IGL Spirits).